Ing. Veronika Vrecionová
ODS
Twitter
NEKONTROLOVÁNO
Obsah příspěvku
The life expectancy for patients with HR+/#HER2- #metastatic disease is low, and it continues to decrease as the disease worsens and patients receive more rounds of chemotherapy. We focus on positively impacting the lives of people with difficult-to-treat breast cancers. #ASCO22 https://t.co/hOg16Myz1x
Screenshot
Screenshot není k dispozici
Metadata
| Platforma | Twitter (social) |
| Publikováno | 04.06.2022 16:56 |
| První viděn | 12.04.2026 00:14 |
| Poslední kontrola | dosud nekontrolováno |
| Počet slov | 0 |
| Hlídač ID | ad054b5ef3c93dd2a216b7d57472cbd4 |
| Original ID | 1533130624122363904 |
| Zdrojová URL | https://twitter.com/vrecionova/status/1533130624122363904 |